These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23456956)

  • 1. Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events.
    Czaja AS; Valuck RJ; Anderson HD
    Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):607-14. PubMed ID: 23456956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Methylphenidate and Selective Serotonin Reuptake Inhibitors in Adults With Attention-Deficit/Hyperactivity Disorder.
    Lee DY; Kim C; Shin Y; Park RW
    JAMA Netw Open; 2024 Oct; 7(10):e2438398. PubMed ID: 39382893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
    Assimon MM; Brookhart MA; Flythe JE
    J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
    Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
    Nephrol Dial Transplant; 2022 Oct; 37(11):2241-2252. PubMed ID: 35793567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
    Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
    Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.
    Ray WA; Chung CP; Murray KT; Hall K; Stein CM
    J Clin Psychiatry; 2017 Feb; 78(2):190-195. PubMed ID: 27736049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults.
    Haddad YK; Kakara R; Marcum ZA
    J Am Geriatr Soc; 2022 May; 70(5):1450-1460. PubMed ID: 35132611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents.
    Sun JW; Hernández-Díaz S; Haneuse S; Bourgeois FT; Vine SM; Olfson M; Bateman BT; Huybrechts KF
    JAMA Psychiatry; 2021 Jan; 78(1):91-100. PubMed ID: 32876659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Serotonin Reuptake Inhibitors and Poststroke Epilepsy: A Population-Based Nationwide Study.
    Chou CC; Yen DJ; Lin YY; Wang YC; Lin CL; Kao CH
    Mayo Clin Proc; 2017 Feb; 92(2):193-199. PubMed ID: 28160872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
    Lam D; Gorman DA; Patten S; Pringsheim T
    Paediatr Drugs; 2013 Aug; 15(4):319-27. PubMed ID: 23529865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Odds of Ventricular Arrhythmias Associated with Selective Serotonin Reuptake Inhibitor Use among the Pediatric and Young Adult Population: A Case-Control Study.
    Czaja AS; Anderson HD; Ghosh D; Davidson J; Campbell JD; Valuck RJ
    J Pediatr; 2020 Nov; 226():173-178.e8. PubMed ID: 32645405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression:
    Kim C; Lee DY; Park J; Yang SJ; Tan EH; Prieto-Alhambra D; Lee YH; Lee S; Kim SJ; Lee J; Park RW; Shin Y
    Psychol Med; 2023 Jul; 53(10):4811-4819. PubMed ID: 36803587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.
    Kawut SM; Horn EM; Berekashvili KK; Lederer DJ; Widlitz AC; Rosenzweig EB; Barst RJ
    Pulm Pharmacol Ther; 2006; 19(5):370-4. PubMed ID: 16483811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitor-induced urinary incontinence.
    Movig KL; Leufkens HG; Belitser SV; Lenderink AW; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002 Jun; 11(4):271-9. PubMed ID: 12138594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
    Labos C; Dasgupta K; Nedjar H; Turecki G; Rahme E
    CMAJ; 2011 Nov; 183(16):1835-43. PubMed ID: 21948719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors.
    Yunusa I; Gagne JJ; Yoshida K; Bykov K
    JAMA Netw Open; 2022 Feb; 5(2):e220194. PubMed ID: 35201310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    Kwak N; Lee H; Kim BK; Yu YM; Kang HY
    J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.